<?xml version="1.0" ?>
<document id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed">
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c0" text="A*02:06-p4 (LTA-J-FLIFL) A*02:07-p5 (LLDS-J-YERL) A*02:07-p6 (LLDSD-J-ERL)"/>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c1" text="A Supporting Information Figure 1 A. Design of 9-, 10-, 11-mer peptides derived from the 15-mer antigen. Overlapping 9-, 10-, 11-mer peptides were each tested for their capability to stabilize the corresponding HLA. A total of 18 different peptides were derived from each 15-mer peptide.">
    <entity charOffset="63-71" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c1.e0" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="133-141" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c1.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="240-248" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c1.e2" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2" text="B. HLA-stability ELISA results for soluble HLA-B*40:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from SARS NP44 15-mer peptide. Non-irradiated HLA with conditional ligand and no peptide added (-UV), irradiated HLA and no peptide added (+UV), or with indicated 9-, 10-, 11-mers peptides. Peptides are labeled as capable (red bars) or incapable (white bars) of stabilizing the corresponding HLA.">
    <entity charOffset="55-64" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="124-132" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="138-142" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <entity charOffset="155-162" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e3" ontology_id="CHEBI_16670" text="peptide" type="chemical"/>
    <entity charOffset="200-206" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e4" ontology_id="CHEBI_52214" text="ligand" type="chemical"/>
    <entity charOffset="214-221" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e5" ontology_id="CHEBI_16670" text="peptide" type="chemical"/>
    <entity charOffset="257-264" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e6" ontology_id="CHEBI_16670" text="peptide" type="chemical"/>
    <entity charOffset="313-321" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e7" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="323-331" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e8" ontology_id="CHEBI_16670" text="Peptides" type="chemical"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e0" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p0" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e1" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p1" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e3" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p2" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e4" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p3" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e5" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p4" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e6" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p5" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e7" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p6" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e2" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.e8" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c2.p7" relation="true"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3" text="C. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*40:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from SARS NP65 15-mer peptide.">
    <entity charOffset="74-83" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="143-151" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="157-161" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.e2" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.e0" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.e2" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.p0" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.e1" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.e2" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c3.p1" relation="true"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c4" text="D. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*55:02 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from DENV NS3-108 15-mer peptide.">
    <entity charOffset="74-83" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c4.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="143-151" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c4.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5" text="E. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*58:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from SARS 3a2 15-mer peptide.">
    <entity charOffset="74-83" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="143-151" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="157-161" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.e2" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.e0" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.e2" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.p0" relation="true"/>
    <pair e1="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.e1" e2="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.e2" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c5.p1" relation="true"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c6" text="F. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*58:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from HBV Pol33 15-mer peptide.">
    <entity charOffset="74-83" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c6.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="143-151" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c6.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c7" text="G. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*58:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from HBV Env72 15-mer peptide.">
    <entity charOffset="74-83" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c7.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="143-151" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c7.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c8" text="H.Similar to Part B, HLA-stability ELISA results for soluble HLA-C*08:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from HBV Env34 15-mer peptide.">
    <entity charOffset="73-82" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c8.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="142-150" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c8.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
  </chunk>
  <chunk id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9" text="I. HLA-stability ELISA results for soluble HLA molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from the indicated15-mer peptide. Non-irradiated HLA with conditional ligand and no peptide added (-UV), irradiated HLA and no peptide added (+UV), or with indicated 9-, 10-, 11-mers peptides.">
    <entity charOffset="47-56" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="116-124" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9.e1" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="150-157" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9.e2" ontology_id="CHEBI_16670" text="peptide" type="chemical"/>
    <entity charOffset="195-201" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9.e3" ontology_id="CHEBI_52214" text="ligand" type="chemical"/>
    <entity charOffset="209-216" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9.e4" ontology_id="CHEBI_16670" text="peptide" type="chemical"/>
    <entity charOffset="252-259" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9.e5" ontology_id="CHEBI_16670" text="peptide" type="chemical"/>
    <entity charOffset="308-316" id="ee06cad1229867a6389ed8a7aaffb5148dd5f8ed.c9.e6" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
  </chunk>
</document>
